Orthopedic fixation technology developer Ossio announced today that it closed a $38.5 million Series C financing round.
Growth equity firm MVM Partners led the funding. Current shareholders also participated in the round.
“We are delighted to have secured this level of interest and commitment from such an experienced and distinguished medical technology investment firm,” said Ossio CEO Brian Verrier. “The additional funding will enable us to accelerate further adoption of Ossiofiber intelligent bone regeneration technology by orthopedic and podiatric surgeons in the United States.
“Specifically, we intend to use these funds to fortify new product development, sales force expansion, patient outreach and medical education.”
Woburn, Massachusetts-based Ossio develops implants with its Ossiofiber intelligent bone regeneration technology. The company designed it to solve the shortcomings of permanent metal hardware and conventional, resorbable an…